Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · January 14, 2023

Efficacy of NOV03 in the Treatment of Patients With Dry Eye Disease Associated With Meibomian Gland Dysfunction

Ophthalmology

 

Additional Info

Ophthalmology
NOV03 for Dry Eye Disease Associated With Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study
Ophthalmology 2022 Dec 24;[EPub Ahead of Print], J Tauber, GJ Berdy, DL Wirta, S Krösser, JL Vittitow

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading